Cargando…

Evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients

BACKGROUND AND AIMS: The increasing number of cancer patients, together with the development of new palliative care services in Romania, warrants the evaluation of nursing strategies meant to improve the level of comfort of patients who are suffering from advanced cancer. The main objective of the s...

Descripción completa

Detalles Bibliográficos
Autores principales: MITREA, NICOLETA, MOSOIU, DANIELA, VOSIT-STELLER, JULIE, ROGOZEA, LILIANA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111488/
https://www.ncbi.nlm.nih.gov/pubmed/27857517
http://dx.doi.org/10.15386/cjmed-660
_version_ 1782467875942957056
author MITREA, NICOLETA
MOSOIU, DANIELA
VOSIT-STELLER, JULIE
ROGOZEA, LILIANA
author_facet MITREA, NICOLETA
MOSOIU, DANIELA
VOSIT-STELLER, JULIE
ROGOZEA, LILIANA
author_sort MITREA, NICOLETA
collection PubMed
description BACKGROUND AND AIMS: The increasing number of cancer patients, together with the development of new palliative care services in Romania, warrants the evaluation of nursing strategies meant to improve the level of comfort of patients who are suffering from advanced cancer. The main objective of the study was to evaluate the optimal positioning of the subcutaneous (sc) butterfly, in accordance with its resistance in the insertion tissue, the local complications that may occur, and the evaluation of the time of resistance at the insertion site (puncture) with the daily frequency of injectable opioid administration. METHODS: A prospective experimental pilot study was designed and conducted between January and May 2011. Patients admitted to the Hospice Casa Sperantei (Brasov, Romania) with moderate or severe cancer pain, who were receiving subcutaneously opioids, over the age of 18, with normal body index ranging from 18.5 – 22.0, were assigned randomly to one of two groups, after signing the informed consent. In group one, the butterfly was positioned with the needle bevel up – this was considered to be the control group as this modality of inserting the needle is considered standard practice; in group two the butterfly was positioned with the needle bevel down – experimental group. The drugs used for pain relief were sc tramadol for moderate pain and sc morphine for severe pain. RESULTS: Our research supported the hypothesis that the occurrence of local complications coincides with the decrease of sc butterfly resistance in time at the place of insertion, and the sc butterfly has a higher rate of resistance in time at the insertion site if the frequency of injectable opioids administration is lower (twice per day). CONCLUSION: The positioning of the butterflies with the bevel down (experimental group) is associated with a longer resistance in time at the site of insertion, and causes fewer local complications compared to the sc butterflies positioned with the bevel up (control group).
format Online
Article
Text
id pubmed-5111488
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-51114882016-11-17 Evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients MITREA, NICOLETA MOSOIU, DANIELA VOSIT-STELLER, JULIE ROGOZEA, LILIANA Clujul Med Original Research BACKGROUND AND AIMS: The increasing number of cancer patients, together with the development of new palliative care services in Romania, warrants the evaluation of nursing strategies meant to improve the level of comfort of patients who are suffering from advanced cancer. The main objective of the study was to evaluate the optimal positioning of the subcutaneous (sc) butterfly, in accordance with its resistance in the insertion tissue, the local complications that may occur, and the evaluation of the time of resistance at the insertion site (puncture) with the daily frequency of injectable opioid administration. METHODS: A prospective experimental pilot study was designed and conducted between January and May 2011. Patients admitted to the Hospice Casa Sperantei (Brasov, Romania) with moderate or severe cancer pain, who were receiving subcutaneously opioids, over the age of 18, with normal body index ranging from 18.5 – 22.0, were assigned randomly to one of two groups, after signing the informed consent. In group one, the butterfly was positioned with the needle bevel up – this was considered to be the control group as this modality of inserting the needle is considered standard practice; in group two the butterfly was positioned with the needle bevel down – experimental group. The drugs used for pain relief were sc tramadol for moderate pain and sc morphine for severe pain. RESULTS: Our research supported the hypothesis that the occurrence of local complications coincides with the decrease of sc butterfly resistance in time at the place of insertion, and the sc butterfly has a higher rate of resistance in time at the insertion site if the frequency of injectable opioids administration is lower (twice per day). CONCLUSION: The positioning of the butterflies with the bevel down (experimental group) is associated with a longer resistance in time at the site of insertion, and causes fewer local complications compared to the sc butterflies positioned with the bevel up (control group). Iuliu Hatieganu University of Medicine and Pharmacy 2016 2016-10-20 /pmc/articles/PMC5111488/ /pubmed/27857517 http://dx.doi.org/10.15386/cjmed-660 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Original Research
MITREA, NICOLETA
MOSOIU, DANIELA
VOSIT-STELLER, JULIE
ROGOZEA, LILIANA
Evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients
title Evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients
title_full Evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients
title_fullStr Evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients
title_full_unstemmed Evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients
title_short Evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients
title_sort evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111488/
https://www.ncbi.nlm.nih.gov/pubmed/27857517
http://dx.doi.org/10.15386/cjmed-660
work_keys_str_mv AT mitreanicoleta evaluationoftheoptimalpositioningofsubcutaneousbutterflywhenadministeringinjectableopioidsincancerpatients
AT mosoiudaniela evaluationoftheoptimalpositioningofsubcutaneousbutterflywhenadministeringinjectableopioidsincancerpatients
AT vositstellerjulie evaluationoftheoptimalpositioningofsubcutaneousbutterflywhenadministeringinjectableopioidsincancerpatients
AT rogozealiliana evaluationoftheoptimalpositioningofsubcutaneousbutterflywhenadministeringinjectableopioidsincancerpatients